Clinical Trials Browser

Terminated × Fallopian Tube Neoplasms × Oxaliplatin × Clear all

NCT02419495 2025-06-04

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

BreastDermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT01936974 2018-02-20

PGA

Phase 2 Terminated

7 enrolled 1 chart

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00418093 2014-06-19

Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

Phase 2 Terminated

19 enrolled 10 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms